The healthcare research specialist unveiled its first set of quarterly figures for 2026.

ICLR is tapping CRO demand, AI workflows and wider trial access, but uneven revenue trends and margin resets keep its ...

Shares of ICON Public Limited (ICLR) traded lower in extended trading after the contract research organization fell short of street forecasts with its Q4 2025 earnings results, which were delayed due ...

Drug and medical device maker ICON agrees to buy PRA Health Sciences in a cash-and-stock transaction valued at about $12 billion.

ICON delivered a modest 1Q26 beat, with EPS of $2.50 and revenue of $2.03B, but growth was subdued and margins compressed.

ICON plc ICLR is well-poised to grow in the upcoming quarters, driven by its strategic additions. Leveraging AI and technology advancements, the company is optimizing clinical delivery and has seen ...

Price change The price of ICLR shares has decreased $2.22 since the market last closed. This is a 1.30% drop. Closed at $168.72. The stock has remained unchanged in after-hours trading.

View Icon Energy Corp. ICON stock quote prices, financial information, real-time forecasts, and company news from CNN.